跳至主要内容
临床试验/NCT04679805
NCT04679805终止不适用

Impact of Coronary Angioplasty on Non-hyperaemic Pressure Ratio in Patients With Coronary Artery Disease.

Ceric Sàrl1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2021年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Ceric Sàrl
入组人数
3
试验地点
1
主要终点
RFRpre vs. RFRfinal

研究概览

简要总结

The use of intra coronary physiological assessment with fractional flow reserve (FFR) is nowadays the standard approach to define ischemia-inducing stenosis and guide myocardial revascularization strategy in patients with coronary artery disease. Further, FFR has been shown to be a strong and independent predictor of major adverse cardiac events after stent implantation. A lower value of FFR after stent implantation is associated with a worse clinical prognosis, without a clearly defined threshold above which clinical follow up are similar for all FFR values. Among 750 patients in the Fractional Flow Reserve Post-Stent Registry, the event rate was 29.5% in patients with FFR<0.80 compared to 9 4.9% in patients with FFR>0.95 (p<0.001). However, FFR remains poorly adopted in many cathlabs, partly because of procedural time, discomfort or sides effect during hyperemia, non-uniform adenosine response and economical constraints. This leads to the validation of resting indices (instantaneous wave-free ratio (iFR), diastolic pressure ratio (dPR), and resting full-cycle ratio (RFR) among others). Those indices evaluate coronary physiology without the use of maximal hyperemia and have 15 slightly different threshold compared to FFR (≤0.89 vs 0.80, for iFR and RFR, and FFR 16 respectively).In the VALIDATE RFR study, a head-to-head comparison of RFR and iFR from a retrospective analysis, diagnostic accuracy of RFR was 97.4% with an area under the curve 1 (AUC) of 99.6%. In the more recent RE-VALIDATE RFR study, 431 patients with 501 lesions 2 were prospectively evaluated for the diagnostic performance of RFR in all-comers patients. Compared to iFR, RFR achieved high diagnostic accuracy, sensitivity and specificity. These are the reasons why we designed a prospective, non-randomized, clinical trial, to better 18 explore the value of RFR before and after PCI in real live and after optimization by post dilation 19 in all-comers patients with coronary artery disease in the Middle East region..

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is ≥ 21 years
  • The patient is deemed eligible for PCI of at least one coronary stenosis (RFRpre ≤0.89 or FFR≤0.80)
  • The patient is able and is willing to comply with all study procedures and process.

排除标准

  • The patient is in cardiogenic shock
  • The patient has a bifurcation lesion that requires a planned two stents technique
  • The patient refuses to participate.
  • The patient suffers acute coronary syndrome and should be treated by PCI in the culprit lesion (non-culprit lesions in non-culprit vessel could be included)
  • The patient has an ostial stenosis to be treated by PCI

结局指标

主要结局

RFRpre vs. RFRfinal

时间窗: Intra operative, up to 1 month

comparison between RFR (Resting Full Cycle Ratio) before and after optimized PCI (RFRpre vs. RFRfinal) in all included lesions

次要结局

  • FFRpre vs. FFRfinal(Intra operative, up to 1 month)
  • RFRpre vs. FFRpre: % of lesions(Intra operative, up to 1 month)
  • The rate of Major Adverse Coronary Events(Day 1 and Day 30)
  • RFRpre vs. RFRpost(Intra operative, up to 1 month)
  • RFRpost vs. RFRfinal(Intra operative, up to 1 month)
  • FFRpre vs. FFRpost(Intra operative, up to 1 month)
  • FFRpost vs. FFRfinal(Intra operative, up to 1 month)
  • RFRpost vs. FFRpost/ % of lesions(Intra operative, up to 1 month)
  • RFRfinal vs. FFRfinal/ % of lesions(Intra operative, up to 1 month)
  • The rate of all cause mortality(Day 1 and Day 30)
  • Contrastpost vs. Contrastfinal.(Intra operative, up to 1 month)
  • % of patients: RFRpost vs. RFRfinal(Intra operative, up to 1 month)
  • The rate of Stent Thrombosis(Day 1 and Day 30)
  • Proc Timepost vs. Proc Timefinal.(Intra operative, up to 1 month)
  • Irradiationpost vs. Irradiationfinal.(Intra operative, up to 1 month)

研究者

发起方
Ceric Sàrl
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Physio PCI: Impact of Coronary Angioplasty on... | 临床试验